Short circulation lifetime, poor blood-brain barrier (BBB) permeability and low targeting specificity limit nanovehicles from crossing the vascular barrier and reaching the
tumor site. Consequently, the precise diagnosis of malignant
brain tumors remains a great challenge. This study demonstrates the imaging of photostable
biopolymer-coated
nanodiamonds (
NDs) with
tumor targeting properties inside the brain.
NDs are labeled with PEGylated denatured
bovine serum albumin (BSA) and
tumor vasculature targeting tripeptides RGD. The modified
NDs show high colloidal stability in different
buffer systems. Moreover, it is found that discrete dcBSA-PEG-
NDs cross the in vitro BBB model more effectively than aggregated
NDs. Importantly, compared with the non-targeting
NDs, RGD-dcBSA-PEG-
NDs can selectively target the
tumor site in U-87 MG bearing mice after systemic injection. Overall, this discrete ND system enables efficacious
brain tumor visualization with minimal toxicity to other major organs, and is worthy of further investigation into the applications as a unique platform for noninvasive theragnostics and/or thermometry at different stages of human diseases in the brain.